• Today April 10
December 03, 2018 20:00
Vitruvias Therapeutics Inc., and Sunny Pharmtech Inc., Announce the FDA Approval of Generic Aminocaproic Acid 500 mg and 1000 mg Tablets
Sunny Pharmtech, Inc., a Taiwan-based API and finished-dose drug development company, and Vitruvius Therapeutics Inc., an Auburn, Alabama-based generic drug company announced today that their Abbrevia
December 03, 2018 19:50
FPT Television Selects Telaria to Manage and Monetize Connected TV Inventory Programmatically
FPT Television, the leading pioneer of IPTV services in Vietnam, today announced it has selected Telaria (NYSE:TLRA), the complete software platform to manage video advertising for premium publishers,
December 03, 2018 19:45
Char Popp Joins PSB as Senior Vice President and Global Head of Qualitative Research
PSB, a global research-based consultancy, announced today that Char Popp has joined the firm as Senior Vice President and Global Head of Qualitative Research to oversee the growth and development of t
December 03, 2018 19:35
ACM Global Laboratories Appoints Brian Wright as President
Rochester Regional Health (RRH), a $2.2 USD billion integrated health care delivery system with more than 17,000 employees, has announced that its wholly-owned subsidiary, ACM Global Laboratories, has
December 03, 2018 19:25
An Unprecedented Initiative Supported By the United Arab Emirates
“A common vision for Arab Digital Economy” is the bold plan driven by the Council of Arab Economic Unity (CAEU) at the League of Arab States to boost political and social stability in the Arab World t
December 03, 2018 18:30
AerSale Acquires Avborne to Expand MRO Capabilities
AerSale®, a global supplier of mid-life aircraft, engines, used serviceable material, and maintenance, repair, and overhaul (MRO) services, today announced it has acquired aircraft component repair sp
December 03, 2018 17:35
The Fukushima I Want to Show the World Photo Contest 2018; Fukushima International Association's Announcement of the Prize-Winning Photos
Fukushima International Association recently held a photo contest for foreign residents living in Fukushima. We received many photos and messages from foreign residents who wanted to demonstrate Fukus
December 03, 2018 17:15
Andersen Global Announces Expansion of Global Board
Andersen Global announced today the expansion of its Global Board of Directors with two new board members: Seyi Bickersteth, Partner at Andersen Tax in Nigeria, and Lena Hamdi, Partner at Andersen Tax
December 03, 2018 17:10
Sigma Systems Newly Included within the Gartner November 2018 Magic Quadrant for Configure, Price and Quote Application Suites
Sigma Systems, the global leader in catalog-driven software, today announced that Sigma Systems has been recognized and placed for the first time within the Gartner November 2018 Magic Quadrant for Co
December 03, 2018 16:55
GSMA Announces First Details for MWC19 Shanghai
The GSMA today announced the first details of MWC19 Shanghai (formerly Mobile World Congress Shanghai), including participating companies, as well as a range of programmes and activities taking place
December 03, 2018 15:45
European Commission Approves ALUNBRIG® (brigatinib) for ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib, Advancing Treatment Paradigm in Europe
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission (EC) granted marketing authorization for ALUNBRIG (brigatinib) as a monotherapy for the treatment of adul
December 03, 2018 14:25
Celgene Corporation Announces Results of AUGMENT Evaluating REVLIMID® In Combination with Rituximab (R2) In Patients with Relapsed/Refractory Indolent Lymphoma At ASH 2018
Celgene Corporation (NASDAQ: CELG) today announced results of the phase 3 AUGMENT study, which showed that REVLIMID® (lenalidomide) in combination with rituximab (R2) demonstrated superior progression
December 03, 2018 13:55
Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 MEDALIST Trial Evaluating Luspatercept in Patients with Myelodysplastic Syndromes at the ASH 2018 Plenary Session
Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from the pivotal, phase 3 MEDALIST trial evaluating the efficacy and safety of investigational luspa
December 03, 2018 13:05
Celgene Corporation Announces Initial Phase 1/2 Liso-cel Data in Patients with Relapsed/Refractory CLL, Including Those with High-Risk Disease, Previously Treated with Ibrutinib, at ASH 2018
Celgene Corporation (NASDAQ: CELG) today announced initial data from the dose-escalation part of an ongoing, open-label multicenter phase 1/2 study of investigational lisocabtagene maraleucel (liso-ce
December 03, 2018 11:55
Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018
Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a pivotal, phase 3 trial (BELIEVE) evaluating the safety and efficacy of luspatercept for the t
December 03, 2018 09:10
Marriott Announces Starwood Guest Reservation Database Security Incident
Marriott has taken measures to investigate and address a data security incident involving the Starwood guest reservation database. On November 19, 2018, the investigation determined that there was una
December 01, 2018 22:50
Ludos Protocol Continues High Profile Marketing Campaign with Times Square Advertisements
Ludos Protocol, the outstanding blockchain infrastructure to solve latency problems in gaming industry, secured coveted spots on a highly-visible Times Square’s digital billboard as part of its compre
December 01, 2018 22:15
Brightline Initiative Study Identifies Crisis Mode Learnings that Create Stronger Strategy Implementation Capabilities
In partnership with Quartz Insights, Brightline™ Initiative today announces the release of research report “Learning From Crisis Mode - Implications for Better Strategy Implementation”. The report aim
December 01, 2018 22:00
Chinese Youth Wallets Are the Target: A US$9 Trillion Digital Youthquake
The battle is on for the hearts, minds (and wallets) of Chinese Millennials. According to Futurologist Rocky Scopelliti who has just released a new book Youthquake 4.0 - A Whole Generation and The New
December 01, 2018 21:45
FedEx Institute of Technology Partners with XYO Network to Build Out Location-Based Technology Capabilities
XYO Network, the technology bringing blockchain to the real world, today announced it will partner with FedEx Institute of Technology to jointly explore benefits and opportunities based on XYO’s work
December 01, 2018 21:20
Citco Launches CitcoConnect: a New Stand-Alone Solution for Secure Data Sharing & Digital Investment
The Citco Group of Companies (“Citco”), a leading global services provider for the financial services industry, today announced the launch of CitcoConnect, a new digital solution that automates and si
December 01, 2018 21:00
Asana Raises $50 Million Series E Funding to Fuel International Growth and Enterprise Scale
Asana, a leading work management platform for teams, today announced the completion of its $50 million Series E equity round at a valuation of $1.5 billion. The round was led by Generation Investme
December 01, 2018 20:50
Aqdar World Summit Concludes with Recommendations on Human Empowerment
The second edition of ‘Aqdar World Summit’, launched in Abu Dhabi on November 26, concluded on Wednesday at the Abu Dhabi National Exhibition Centre -ADNEC. Held under the title “Role of Human Empower
December 01, 2018 20:30
Virgin Voyages to Have New Palm Grove Home Terminal at PortMiami in 2021
Virgin Group Founder Sir Richard Branson and Virgin Voyages President and CEO Tom McAlpin were joined today by Miami-Dade County Mayor Carlos A. Gimenez, Chairwoman of the Miami-Dade County Economic D
November 30, 2018 18:00
FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain
SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using its universal donor product, CybroCell™, today announced the FDA has cleared its Inves
25 per page50 per page75 per page100 per page